MFAP4 and cancer: Second, MFAP4 and EFEMP1 have been well studied in various cancers, and the intricate mechanisms underlying the upregulation of MFAP4 and EFEMP1 in platinum-resistant OC patients remain unclear, necessitating further exploration in future research.